Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. - Braganca Xavier C; Andersen CR; Lim J; Slade JH; Bean SA; Kang L; Le H; Tsimberidou AM; Naing A; Hong DS; Dumbrava EE; Rodon Ahnert J; et al. (Cancer research communications, 2025)